Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanadelumab for Dialysis-Induced Hypotension
NCT05297786Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Jul 2022
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
A Phase 2 trial of lanadelumab in hypotension, sponsored by Vanderbilt University Medical Center. Started Jul 2022; status: completed.
02
Drugs
lanadelumab
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05297786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05297786.